| US Orphan Drug Designation Application | 30-Oct-2025 | 07:00 | RNS |
| Positive Preclinical Data in Prostate Cancer | 14-Oct-2025 | 07:00 | RNS |
| Half Year Report | 15-Sep-2025 | 07:00 | RNS |
| Notice of Interim Results and IMC Presentation | 12-Sep-2025 | 07:00 | RNS |
| Approval for phase 2 clinical trial | 01-Sep-2025 | 07:00 | RNS |
| Result of AGM | 26-Aug-2025 | 16:03 | RNS |
| AGM Statement | 26-Aug-2025 | 07:00 | RNS |
| GMP Manufacture of ChemoSeed | 12-Aug-2025 | 07:00 | RNS |
| Notice of AGM and EMI Option Plan | 04-Aug-2025 | 17:45 | RNS |
| Holding(s) in Company | 10-Jul-2025 | 15:04 | RNS |
| Result of Retail Offer and Additional Placing | 03-Jul-2025 | 07:00 | RNS |
| Submission of CTA Application | 01-Jul-2025 | 07:00 | RNS |
| Retail Offer | 30-Jun-2025 | 07:01 | RNS |
| Placing | 30-Jun-2025 | 07:00 | RNS |
| Final Results for the year ended 31 December 2024 | 13-Jun-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 11.75p |
| Change Today | 1.25p |
| % Change | 11.90 % |
| 52 Week High | 12.50 |
| 52 Week Low | 10.50 |
| Volume | 328,061 |
| Shares Issued | 39.96m |
| Market Cap | £4.70m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Latest | Previous | |
|---|---|---|
| Special | Interim | |
| Ex-Div | 01-Jun-23 | n/a |
| Paid | 14-Jun-23 | n/a |
| Amount | 1.80p | 0.000¢ |
| Time | Volume / Share Price |
| 16:28 | 25,000 @ 12.42p |
| 16:22 | 1,900 @ 12.42p |
| 15:53 | 10,000 @ 12.43p |
| 15:28 | 1,571 @ 12.47p |
| 14:52 | 40 @ 12.50p |
| CEO | Andrew James Webb |
You are here: research